Allulose is not a carcinogen based on all available safety testing. Multiple independent safety reviews submitted to the FDA have concluded that allulose is non-genotoxic (doesn’t damage DNA) and non-carcinogenic, drawing on long-term animal studies and laboratory tests designed specifically to detect cancer-causing potential.
What the Safety Testing Actually Found
The question of whether a food ingredient causes cancer is answered through a specific set of studies. For allulose, these have included laboratory tests that expose bacterial and mammalian cells to the substance to see if it causes genetic mutations, plus long-term feeding studies in rodents lasting up to 18 months. An 18-month chronic feeding study in rats, along with multiple shorter studies (90-day and 12-week feeding trials in rats and dogs), found no evidence of tumor formation or DNA damage at any dose tested.
These results have been reviewed by the FDA multiple times. The agency has issued “no questions” letters for several independent GRAS (Generally Recognized as Safe) notices for allulose, meaning the FDA reviewed the safety data and had no objections to the conclusion that allulose is safe for use in food. At least three separate GRAS notifications have been accepted, submitted by different companies using their own safety data.
Why Your Body Barely Processes It
Part of what makes allulose unlikely to cause harm is how little your body actually does with it. About 70% of the allulose you eat gets absorbed in the small intestine, but instead of being broken down for energy like regular sugar, most of it passes through your system unchanged and is excreted in urine. The portion that isn’t absorbed in the small intestine reaches the large intestine, where gut bacteria can ferment it, but even that process is minimal.
This is why the FDA classifies allulose at no more than 0.4 calories per gram, compared to 4 calories per gram for regular sugar. It’s also why allulose produces only a negligible increase in blood sugar and insulin levels. A substance that passes through the body largely untouched has very little opportunity to interact with cells in ways that could promote cancer.
The European Regulatory Gap
If you’ve seen headlines suggesting allulose hasn’t been proven safe, they likely trace back to Europe. The European Food Safety Authority (EFSA) was asked to evaluate allulose as a novel food, but during the review process, the agency requested additional data from the applicant on topics including the production process, proposed uses, genotoxicity details, and human data. The applicant never responded, despite multiple follow-ups. EFSA concluded that safety “cannot be established” for allulose in Europe, but this wasn’t because they found evidence of harm. It was because they never received the information they asked for.
Allulose remains unavailable as a food ingredient in the EU because of this incomplete application, not because of a safety concern that contradicts the FDA’s findings. The distinction matters: a failed paperwork process is not the same as a failed safety test.
Known Side Effects at High Doses
The real practical concern with allulose isn’t cancer but digestive discomfort. Research in healthy adults has established that single doses above about 0.4 grams per kilogram of body weight can cause bloating, gas, or a laxative effect. For a 150-pound person, that threshold works out to roughly 27 grams in one sitting. The no-observed-effect level for laxative symptoms is slightly higher, at about 0.55 grams per kilogram of body weight (around 37 grams for the same person).
These thresholds are worth knowing because allulose is showing up in more and more products, from protein bars to ice cream to baked goods. If you’re eating multiple allulose-sweetened foods in a short window, digestive symptoms are possible. Spreading your intake across the day reduces the likelihood. Allulose also doesn’t promote tooth decay, which sets it apart from regular sugar and even some other sugar substitutes.
The Bottom Line on Cancer Risk
Every standard cancer-screening test applied to allulose has come back negative. Long-term animal feeding studies show no tumor formation. Cell-based mutation tests show no DNA damage. The FDA has reviewed these findings multiple times from multiple submitters and raised no objections. While no food ingredient can be declared risk-free with absolute certainty, the evidence base for allulose is robust and consistently points in one direction: it does not cause cancer.